Synergy of a Herpes Oncolytic Virus and Paclitaxel for Anaplastic Thyroid Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-07-4628
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

A Fusogenic Oncolytic Herpes Simplex Virus for Therapy of Advanced Ovarian Cancer

2005English

A Potent Oncolytic Herpes Simplex Virus for the Therapy of Advanced Prostate Cancer

2004English

Biochemical Effects of Combined Action of ?-Irradiation and Paclitaxel on Anaplastic Thyroid Cancer Cells

Ukrainian Biochemical Journal
Biochemistry
2013English

Treatment of Breast Cancer Stem Cells With Oncolytic Herpes Simplex Virus

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2012English

409. Therapeutic Efficacy of Oncolytic Herpes Virus and Chemotherapy for Treatment of Late-Stage Ovarian Cancer

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

Oncolytic Herpes Virus Retargeted to HER-2

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2009English

Unusual Manifestation of Anaplastic Thyroid Cancer

Acta medica (Hradec Kralove)
Medicine
2008English

Recent Progress of Genome Study for Anaplastic Thyroid Cancer

Genomics and Informatics
EvolutionEcologyGeneticsSystematicsHealth InformaticsBehavior
2013English

Hypoxia Enhances the Replication of Oncolytic Herpes Simplex Virus in P53- Breast Cancer Cells

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy